ArticleTranslational cancer research2025
SNX24 serves as a potential prognostic biomarker and a therapeutic target in uterine corpus endometrial carcinoma according to bioinformatics and experimentations.
Delai Long et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.